Agilent Revs up Precision Medicine Push with Planned Resolution Bioscience Acquisition
March 3, 2021
[Source: Getty Images North America]
In a planned acquisition aimed at expanding its next-generation sequencing (NGS)-based capabilities in cancer diagnostics, Agilent Technologies announced yesterday it has agreed to buy Resolution Bioscience for up to $695 million.
Once rolled into the company, Resolution Bioscience’s liquid biopsy platform will complement Agilent’s existing tissue-based companion diagnostics business. In total, Agilent says the addressable market for these diagnostic tests is expected to be $3 billion by 2025, and double that by the end of the decade.
“By adding Resolution Bioscience’s liquid biopsy-based diagnostic technologies to our portfolio, we are strengthening Agilent’s offering to our biopharma customers and boosting the growth of our diagnostics and genomics business,” Agilent president and CEO Mike McMullen said in a statement.
Quidel QuickVue At-Home COVID-19 Test Granted FDA Authorization sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.
March 2, 2021 10:48 GMT
Determining whether one is infected with COVID-19 could now become much easier. The U.S. Food and Drug Administration (FDA) issued an emergency use authorisation on a rapid home-test kit that will yield the result in a matter of 10 minutes.
One can avail of these tests through a prescription and those who can use it are individuals who are 14 years old and older. Although those who are eight years old and above can also use the test, the presence of an adult is a requirement to collect the nasal swab sample among younger individuals.
New name for long COVID: Fauci refers to long-term coronavirus effects as PASC
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Quidel QuickVue At-Home COVID-19 Test, another antigen test where certain individuals can rapidly collect and test their sample at home, without needing to send a sample to a laboratory for analysis.